Zimmer and Anika expand Orthovisc deal:
This article was originally published in Clinica
Executive Summary
Zimmer and Anika Therapeutics have extended their exclusive, multi-year distribution agreement for Orthovisc, an injectable product based on hyaluronic acid to restore the elasticity and viscosity of the synovial fluid. Under the new agreement, Zimmer will sell the product in Europe and Latin America. Anika will receive up to $3.5 million. The two companies' initial agreement covered the US, Canada and certain Asia-Pacific countries.